Review





Similar Products

90
Millipore recombinant human β-amyloid (1–42; ultrapure)
Recombinant Human β Amyloid (1–42; Ultrapure), supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant human β-amyloid (1–42; ultrapure)/product/Millipore
Average 90 stars, based on 1 article reviews
recombinant human β-amyloid (1–42; ultrapure) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
GenicBio BioTech Co Ltd recombinant aβ peptides aβ 1–42, tfa
Recombinant Aβ Peptides Aβ 1–42, Tfa, supplied by GenicBio BioTech Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant aβ peptides aβ 1–42, tfa/product/GenicBio BioTech Co Ltd
Average 90 stars, based on 1 article reviews
recombinant aβ peptides aβ 1–42, tfa - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Thermo Fisher human beta-amyloid 1-42 protein transduction domain recombinant 03- 112
Human Beta Amyloid 1 42 Protein Transduction Domain Recombinant 03 112, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human beta-amyloid 1-42 protein transduction domain recombinant 03- 112/product/Thermo Fisher
Average 90 stars, based on 1 article reviews
human beta-amyloid 1-42 protein transduction domain recombinant 03- 112 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
rPeptide human recombinant aβ 1−42
Human Recombinant Aβ 1−42, supplied by rPeptide, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human recombinant aβ 1−42/product/rPeptide
Average 90 stars, based on 1 article reviews
human recombinant aβ 1−42 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
ChinaPeptides recombinant human aβ 1−42 peptide
GGT5 expression is downregulated in Aβ 1–42 –treated hCMEC/D3 and bEnd.3 cells and in the brains of APP/PS1 mice. (A) mRNA-seq analysis of hCMEC/D3 cells identified 178 genes that were differentially expressed between the vehicle and Aβ 1–42 intervention groups. (B) Nine downregulated genes and two upregulated genes were selected by comparing the 178 differentially expressed genes with an existing AD single-cell sequencing database. (C) qPCR verification of the expression levels of the 11 selected genes ( n = 3 per group). (D, E) Representative western blots (D) and quantitative analysis (E) of AGRN, LRP1, and GGT5 expression in hCMEC/D3 cells treated with vehicle or Aβ 1–42 (each row is an image from a different blot) ( n = 3–4 per group). (F, G) Representative western blots (F) and quantitative analysis (G) of GGT5 expression in bEnd.3 cells treated with vehicle or Aβ 1–42 ( n = 4 per group). (H–K) Representative western blots of GGT5 and Aβ in the Ctx (H) and Hip (I) and quantitative analysis of GGT5 (J) and Aβ (K) expression in the Ctx and Hip of mice ( n = 4 per group). Data are expressed as mean ± SEM. * P < 0.05, *** P < 0.001 (one-way analysis of variance followed by Tukey’s post hoc test [J and K], or independent-samples t -test [C, E and G]). AD: Alzheimer’s disease; AGRN: Agrin; ARHGEF17: Rho guanine nucleotide exchange factor (GEF) 17; Aβ: amyloid-β; Ctx: cortex; GAPDH: glyceraldehyde-3-phosphate dehydrogenase; GGT5: gamma-glutamyltransferase 5; Hip: hippocampus; LRP1: low density lipoprotein receptor related protein 1; MCAM: melanoma cell adhesion molecule; MRC2: mannose receptor c type 2; PLOD1: procollagen lysine-1,2-oxoglutarate-5-dioxygenase 1; RPS27A: ribosomal protein S27A; WT: wide type.
Recombinant Human Aβ 1−42 Peptide, supplied by ChinaPeptides, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant human aβ 1−42 peptide/product/ChinaPeptides
Average 90 stars, based on 1 article reviews
recombinant human aβ 1−42 peptide - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
rPeptide recombinant lyophilized aβ 42 a-1163-1
GGT5 expression is downregulated in Aβ 1–42 –treated hCMEC/D3 and bEnd.3 cells and in the brains of APP/PS1 mice. (A) mRNA-seq analysis of hCMEC/D3 cells identified 178 genes that were differentially expressed between the vehicle and Aβ 1–42 intervention groups. (B) Nine downregulated genes and two upregulated genes were selected by comparing the 178 differentially expressed genes with an existing AD single-cell sequencing database. (C) qPCR verification of the expression levels of the 11 selected genes ( n = 3 per group). (D, E) Representative western blots (D) and quantitative analysis (E) of AGRN, LRP1, and GGT5 expression in hCMEC/D3 cells treated with vehicle or Aβ 1–42 (each row is an image from a different blot) ( n = 3–4 per group). (F, G) Representative western blots (F) and quantitative analysis (G) of GGT5 expression in bEnd.3 cells treated with vehicle or Aβ 1–42 ( n = 4 per group). (H–K) Representative western blots of GGT5 and Aβ in the Ctx (H) and Hip (I) and quantitative analysis of GGT5 (J) and Aβ (K) expression in the Ctx and Hip of mice ( n = 4 per group). Data are expressed as mean ± SEM. * P < 0.05, *** P < 0.001 (one-way analysis of variance followed by Tukey’s post hoc test [J and K], or independent-samples t -test [C, E and G]). AD: Alzheimer’s disease; AGRN: Agrin; ARHGEF17: Rho guanine nucleotide exchange factor (GEF) 17; Aβ: amyloid-β; Ctx: cortex; GAPDH: glyceraldehyde-3-phosphate dehydrogenase; GGT5: gamma-glutamyltransferase 5; Hip: hippocampus; LRP1: low density lipoprotein receptor related protein 1; MCAM: melanoma cell adhesion molecule; MRC2: mannose receptor c type 2; PLOD1: procollagen lysine-1,2-oxoglutarate-5-dioxygenase 1; RPS27A: ribosomal protein S27A; WT: wide type.
Recombinant Lyophilized Aβ 42 A 1163 1, supplied by rPeptide, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant lyophilized aβ 42 a-1163-1/product/rPeptide
Average 90 stars, based on 1 article reviews
recombinant lyophilized aβ 42 a-1163-1 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
rPeptide human recombinant amyloid β protein fragment 1-42 (aβ1-42)
GGT5 expression is downregulated in Aβ 1–42 –treated hCMEC/D3 and bEnd.3 cells and in the brains of APP/PS1 mice. (A) mRNA-seq analysis of hCMEC/D3 cells identified 178 genes that were differentially expressed between the vehicle and Aβ 1–42 intervention groups. (B) Nine downregulated genes and two upregulated genes were selected by comparing the 178 differentially expressed genes with an existing AD single-cell sequencing database. (C) qPCR verification of the expression levels of the 11 selected genes ( n = 3 per group). (D, E) Representative western blots (D) and quantitative analysis (E) of AGRN, LRP1, and GGT5 expression in hCMEC/D3 cells treated with vehicle or Aβ 1–42 (each row is an image from a different blot) ( n = 3–4 per group). (F, G) Representative western blots (F) and quantitative analysis (G) of GGT5 expression in bEnd.3 cells treated with vehicle or Aβ 1–42 ( n = 4 per group). (H–K) Representative western blots of GGT5 and Aβ in the Ctx (H) and Hip (I) and quantitative analysis of GGT5 (J) and Aβ (K) expression in the Ctx and Hip of mice ( n = 4 per group). Data are expressed as mean ± SEM. * P < 0.05, *** P < 0.001 (one-way analysis of variance followed by Tukey’s post hoc test [J and K], or independent-samples t -test [C, E and G]). AD: Alzheimer’s disease; AGRN: Agrin; ARHGEF17: Rho guanine nucleotide exchange factor (GEF) 17; Aβ: amyloid-β; Ctx: cortex; GAPDH: glyceraldehyde-3-phosphate dehydrogenase; GGT5: gamma-glutamyltransferase 5; Hip: hippocampus; LRP1: low density lipoprotein receptor related protein 1; MCAM: melanoma cell adhesion molecule; MRC2: mannose receptor c type 2; PLOD1: procollagen lysine-1,2-oxoglutarate-5-dioxygenase 1; RPS27A: ribosomal protein S27A; WT: wide type.
Human Recombinant Amyloid β Protein Fragment 1 42 (Aβ1 42), supplied by rPeptide, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human recombinant amyloid β protein fragment 1-42 (aβ1-42)/product/rPeptide
Average 90 stars, based on 1 article reviews
human recombinant amyloid β protein fragment 1-42 (aβ1-42) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
rPeptide recombinant human ab1-42 a-1170-1
GGT5 expression is downregulated in Aβ 1–42 –treated hCMEC/D3 and bEnd.3 cells and in the brains of APP/PS1 mice. (A) mRNA-seq analysis of hCMEC/D3 cells identified 178 genes that were differentially expressed between the vehicle and Aβ 1–42 intervention groups. (B) Nine downregulated genes and two upregulated genes were selected by comparing the 178 differentially expressed genes with an existing AD single-cell sequencing database. (C) qPCR verification of the expression levels of the 11 selected genes ( n = 3 per group). (D, E) Representative western blots (D) and quantitative analysis (E) of AGRN, LRP1, and GGT5 expression in hCMEC/D3 cells treated with vehicle or Aβ 1–42 (each row is an image from a different blot) ( n = 3–4 per group). (F, G) Representative western blots (F) and quantitative analysis (G) of GGT5 expression in bEnd.3 cells treated with vehicle or Aβ 1–42 ( n = 4 per group). (H–K) Representative western blots of GGT5 and Aβ in the Ctx (H) and Hip (I) and quantitative analysis of GGT5 (J) and Aβ (K) expression in the Ctx and Hip of mice ( n = 4 per group). Data are expressed as mean ± SEM. * P < 0.05, *** P < 0.001 (one-way analysis of variance followed by Tukey’s post hoc test [J and K], or independent-samples t -test [C, E and G]). AD: Alzheimer’s disease; AGRN: Agrin; ARHGEF17: Rho guanine nucleotide exchange factor (GEF) 17; Aβ: amyloid-β; Ctx: cortex; GAPDH: glyceraldehyde-3-phosphate dehydrogenase; GGT5: gamma-glutamyltransferase 5; Hip: hippocampus; LRP1: low density lipoprotein receptor related protein 1; MCAM: melanoma cell adhesion molecule; MRC2: mannose receptor c type 2; PLOD1: procollagen lysine-1,2-oxoglutarate-5-dioxygenase 1; RPS27A: ribosomal protein S27A; WT: wide type.
Recombinant Human Ab1 42 A 1170 1, supplied by rPeptide, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant human ab1-42 a-1170-1/product/rPeptide
Average 90 stars, based on 1 article reviews
recombinant human ab1-42 a-1170-1 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
AnaSpec recombinant human peaβ3‐42 as‐29907‐1
GGT5 expression is downregulated in Aβ 1–42 –treated hCMEC/D3 and bEnd.3 cells and in the brains of APP/PS1 mice. (A) mRNA-seq analysis of hCMEC/D3 cells identified 178 genes that were differentially expressed between the vehicle and Aβ 1–42 intervention groups. (B) Nine downregulated genes and two upregulated genes were selected by comparing the 178 differentially expressed genes with an existing AD single-cell sequencing database. (C) qPCR verification of the expression levels of the 11 selected genes ( n = 3 per group). (D, E) Representative western blots (D) and quantitative analysis (E) of AGRN, LRP1, and GGT5 expression in hCMEC/D3 cells treated with vehicle or Aβ 1–42 (each row is an image from a different blot) ( n = 3–4 per group). (F, G) Representative western blots (F) and quantitative analysis (G) of GGT5 expression in bEnd.3 cells treated with vehicle or Aβ 1–42 ( n = 4 per group). (H–K) Representative western blots of GGT5 and Aβ in the Ctx (H) and Hip (I) and quantitative analysis of GGT5 (J) and Aβ (K) expression in the Ctx and Hip of mice ( n = 4 per group). Data are expressed as mean ± SEM. * P < 0.05, *** P < 0.001 (one-way analysis of variance followed by Tukey’s post hoc test [J and K], or independent-samples t -test [C, E and G]). AD: Alzheimer’s disease; AGRN: Agrin; ARHGEF17: Rho guanine nucleotide exchange factor (GEF) 17; Aβ: amyloid-β; Ctx: cortex; GAPDH: glyceraldehyde-3-phosphate dehydrogenase; GGT5: gamma-glutamyltransferase 5; Hip: hippocampus; LRP1: low density lipoprotein receptor related protein 1; MCAM: melanoma cell adhesion molecule; MRC2: mannose receptor c type 2; PLOD1: procollagen lysine-1,2-oxoglutarate-5-dioxygenase 1; RPS27A: ribosomal protein S27A; WT: wide type.
Recombinant Human Peaβ3‐42 As‐29907‐1, supplied by AnaSpec, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant human peaβ3‐42 as‐29907‐1/product/AnaSpec
Average 90 stars, based on 1 article reviews
recombinant human peaβ3‐42 as‐29907‐1 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
rPeptide recombinant human aβ 1-42
GGT5 expression is downregulated in Aβ 1–42 –treated hCMEC/D3 and bEnd.3 cells and in the brains of APP/PS1 mice. (A) mRNA-seq analysis of hCMEC/D3 cells identified 178 genes that were differentially expressed between the vehicle and Aβ 1–42 intervention groups. (B) Nine downregulated genes and two upregulated genes were selected by comparing the 178 differentially expressed genes with an existing AD single-cell sequencing database. (C) qPCR verification of the expression levels of the 11 selected genes ( n = 3 per group). (D, E) Representative western blots (D) and quantitative analysis (E) of AGRN, LRP1, and GGT5 expression in hCMEC/D3 cells treated with vehicle or Aβ 1–42 (each row is an image from a different blot) ( n = 3–4 per group). (F, G) Representative western blots (F) and quantitative analysis (G) of GGT5 expression in bEnd.3 cells treated with vehicle or Aβ 1–42 ( n = 4 per group). (H–K) Representative western blots of GGT5 and Aβ in the Ctx (H) and Hip (I) and quantitative analysis of GGT5 (J) and Aβ (K) expression in the Ctx and Hip of mice ( n = 4 per group). Data are expressed as mean ± SEM. * P < 0.05, *** P < 0.001 (one-way analysis of variance followed by Tukey’s post hoc test [J and K], or independent-samples t -test [C, E and G]). AD: Alzheimer’s disease; AGRN: Agrin; ARHGEF17: Rho guanine nucleotide exchange factor (GEF) 17; Aβ: amyloid-β; Ctx: cortex; GAPDH: glyceraldehyde-3-phosphate dehydrogenase; GGT5: gamma-glutamyltransferase 5; Hip: hippocampus; LRP1: low density lipoprotein receptor related protein 1; MCAM: melanoma cell adhesion molecule; MRC2: mannose receptor c type 2; PLOD1: procollagen lysine-1,2-oxoglutarate-5-dioxygenase 1; RPS27A: ribosomal protein S27A; WT: wide type.
Recombinant Human Aβ 1 42, supplied by rPeptide, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant human aβ 1-42/product/rPeptide
Average 90 stars, based on 1 article reviews
recombinant human aβ 1-42 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


GGT5 expression is downregulated in Aβ 1–42 –treated hCMEC/D3 and bEnd.3 cells and in the brains of APP/PS1 mice. (A) mRNA-seq analysis of hCMEC/D3 cells identified 178 genes that were differentially expressed between the vehicle and Aβ 1–42 intervention groups. (B) Nine downregulated genes and two upregulated genes were selected by comparing the 178 differentially expressed genes with an existing AD single-cell sequencing database. (C) qPCR verification of the expression levels of the 11 selected genes ( n = 3 per group). (D, E) Representative western blots (D) and quantitative analysis (E) of AGRN, LRP1, and GGT5 expression in hCMEC/D3 cells treated with vehicle or Aβ 1–42 (each row is an image from a different blot) ( n = 3–4 per group). (F, G) Representative western blots (F) and quantitative analysis (G) of GGT5 expression in bEnd.3 cells treated with vehicle or Aβ 1–42 ( n = 4 per group). (H–K) Representative western blots of GGT5 and Aβ in the Ctx (H) and Hip (I) and quantitative analysis of GGT5 (J) and Aβ (K) expression in the Ctx and Hip of mice ( n = 4 per group). Data are expressed as mean ± SEM. * P < 0.05, *** P < 0.001 (one-way analysis of variance followed by Tukey’s post hoc test [J and K], or independent-samples t -test [C, E and G]). AD: Alzheimer’s disease; AGRN: Agrin; ARHGEF17: Rho guanine nucleotide exchange factor (GEF) 17; Aβ: amyloid-β; Ctx: cortex; GAPDH: glyceraldehyde-3-phosphate dehydrogenase; GGT5: gamma-glutamyltransferase 5; Hip: hippocampus; LRP1: low density lipoprotein receptor related protein 1; MCAM: melanoma cell adhesion molecule; MRC2: mannose receptor c type 2; PLOD1: procollagen lysine-1,2-oxoglutarate-5-dioxygenase 1; RPS27A: ribosomal protein S27A; WT: wide type.

Journal: Neural Regeneration Research

Article Title: Gamma-glutamyl transferase 5 overexpression in cerebrovascular endothelial cells improves brain pathology, cognition, and behavior in APP/PS1 mice

doi: 10.4103/NRR.NRR-D-23-01525

Figure Lengend Snippet: GGT5 expression is downregulated in Aβ 1–42 –treated hCMEC/D3 and bEnd.3 cells and in the brains of APP/PS1 mice. (A) mRNA-seq analysis of hCMEC/D3 cells identified 178 genes that were differentially expressed between the vehicle and Aβ 1–42 intervention groups. (B) Nine downregulated genes and two upregulated genes were selected by comparing the 178 differentially expressed genes with an existing AD single-cell sequencing database. (C) qPCR verification of the expression levels of the 11 selected genes ( n = 3 per group). (D, E) Representative western blots (D) and quantitative analysis (E) of AGRN, LRP1, and GGT5 expression in hCMEC/D3 cells treated with vehicle or Aβ 1–42 (each row is an image from a different blot) ( n = 3–4 per group). (F, G) Representative western blots (F) and quantitative analysis (G) of GGT5 expression in bEnd.3 cells treated with vehicle or Aβ 1–42 ( n = 4 per group). (H–K) Representative western blots of GGT5 and Aβ in the Ctx (H) and Hip (I) and quantitative analysis of GGT5 (J) and Aβ (K) expression in the Ctx and Hip of mice ( n = 4 per group). Data are expressed as mean ± SEM. * P < 0.05, *** P < 0.001 (one-way analysis of variance followed by Tukey’s post hoc test [J and K], or independent-samples t -test [C, E and G]). AD: Alzheimer’s disease; AGRN: Agrin; ARHGEF17: Rho guanine nucleotide exchange factor (GEF) 17; Aβ: amyloid-β; Ctx: cortex; GAPDH: glyceraldehyde-3-phosphate dehydrogenase; GGT5: gamma-glutamyltransferase 5; Hip: hippocampus; LRP1: low density lipoprotein receptor related protein 1; MCAM: melanoma cell adhesion molecule; MRC2: mannose receptor c type 2; PLOD1: procollagen lysine-1,2-oxoglutarate-5-dioxygenase 1; RPS27A: ribosomal protein S27A; WT: wide type.

Article Snippet: One milligram of recombinant human Aβ 1−42 peptide (ChinaPeptides, Shanghai, China) was dissolved in 60 μL of dimethyl sulfoxide (DMSO) (Li et al., 2022b) and then diluted to the final concentration (5 μM) with complete medium.

Techniques: Expressing, Sequencing, Western Blot

GGT5 overexpression in cerebrovascular endothelial cells reduces the Aβ load in the brains of APP/PS1 mice by inhibiting BACE1. (A–F) Representative western blots (each row is an image from a different blot) (A) and quantitative analysis of flAPP (B), CTF (C), BACE1 (D), total Aβ (E), and Aβ 1–42 (F) expression in the mouse cortex ( n = 3–5 per group). (G–I) Representative western blots (each row is an image from a different blot) (G) and quantitative analysis of BACE1 (H) and total Aβ (I) expression in the mouse hippocampus ( n = 4–5 per group). Data are expressed as mean ± SEM. * P < 0.05, ** P < 0.01, *** P < 0.001 (one-way analysis of variance followed by Tukey’s post hoc test). APP: Amyloid precursor protein; Aβ: amyloid-β; BACE1: β-site APP cleaving enzyme1; CTF: C-terminal fragment; Ctx: cortex; flAPP: full-length APP; GGT5: gamma-glutamyltransferase 5; Hip: hippocampus; WT: wide type.

Journal: Neural Regeneration Research

Article Title: Gamma-glutamyl transferase 5 overexpression in cerebrovascular endothelial cells improves brain pathology, cognition, and behavior in APP/PS1 mice

doi: 10.4103/NRR.NRR-D-23-01525

Figure Lengend Snippet: GGT5 overexpression in cerebrovascular endothelial cells reduces the Aβ load in the brains of APP/PS1 mice by inhibiting BACE1. (A–F) Representative western blots (each row is an image from a different blot) (A) and quantitative analysis of flAPP (B), CTF (C), BACE1 (D), total Aβ (E), and Aβ 1–42 (F) expression in the mouse cortex ( n = 3–5 per group). (G–I) Representative western blots (each row is an image from a different blot) (G) and quantitative analysis of BACE1 (H) and total Aβ (I) expression in the mouse hippocampus ( n = 4–5 per group). Data are expressed as mean ± SEM. * P < 0.05, ** P < 0.01, *** P < 0.001 (one-way analysis of variance followed by Tukey’s post hoc test). APP: Amyloid precursor protein; Aβ: amyloid-β; BACE1: β-site APP cleaving enzyme1; CTF: C-terminal fragment; Ctx: cortex; flAPP: full-length APP; GGT5: gamma-glutamyltransferase 5; Hip: hippocampus; WT: wide type.

Article Snippet: One milligram of recombinant human Aβ 1−42 peptide (ChinaPeptides, Shanghai, China) was dissolved in 60 μL of dimethyl sulfoxide (DMSO) (Li et al., 2022b) and then diluted to the final concentration (5 μM) with complete medium.

Techniques: Over Expression, Western Blot, Expressing